Mesoblast (MESO) Non-Current Deffered Revenue (2018 - 2025)

Mesoblast's (MESO) quarterly Non-Current Deffered Revenue came in at $2.5 million in Q4 2025, little changed year-on-year from $2.5 million in Q4 2024, and little changed quarter-over-quarter from $2.5 million in Q2 2025.

Mesoblast (MESO) Non-Current Deffered Revenue (2018 - 2025) Analysis & Trends

Mesoblast has disclosed Non-Current Deffered Revenue across 8 years of filings, most recently posting $2.5 million for Q4 2025.

  • Non-Current Deffered Revenue for Q4 2025 came in at $2.5 million, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.5 million (changed 0.0% YoY), and the FY2025 annual result was $2.5 million, changed 0.0% from the prior year.
  • Non-Current Deffered Revenue came in at $2.5 million for Q4 2025 at Mesoblast, roughly flat from $2.5 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $2.5 million in Q1 2021 to a low of $2.5 million in Q1 2021.
  • The 5-year median for Non-Current Deffered Revenue is $2.5 million (2021), against an average of $2.5 million.
  • Peak annual rise in Non-Current Deffered Revenue reached 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
  • Mesoblast's Non-Current Deffered Revenue stood at $2.5 million in 2021, then changed by 0.0% to $2.5 million in 2022, then changed by 0.0% to $2.5 million in 2023, then changed by 0.0% to $2.5 million in 2024, then changed by 0.0% to $2.5 million in 2025.
  • The last three Non-Current Deffered Revenue figures came in at $2.5 million (Q4 2025), $2.5 million (Q2 2025), and $2.5 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Mesoblast 21.68 Bn 21.55 Bn - 2.50 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.50 Mn
Jun 30, 2025 2.50 Mn
Dec 31, 2024 2.50 Mn
Jun 30, 2024 2.50 Mn
Dec 31, 2023 2.50 Mn
Jun 30, 2023 2.50 Mn
Mar 31, 2023 2.50 Mn
Dec 31, 2022 2.50 Mn
Sep 30, 2022 2.50 Mn
Jun 30, 2022 2.50 Mn
Mar 31, 2022 2.50 Mn
Dec 31, 2021 2.50 Mn
Sep 30, 2021 2.50 Mn
Jun 30, 2021 2.50 Mn
Mar 31, 2021 2.50 Mn
Dec 31, 2020 2.50 Mn
Sep 30, 2020 2.50 Mn
Jun 30, 2020 2.50 Mn
Mar 31, 2020 2.50 Mn
Dec 31, 2019 10.00 Mn